MetaCap

CalciMedica (CALC) vs Chemomab Therapeutics (CMMB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Chemomab Therapeutics (CMMB) has outperformed CalciMedica (CALC) over the past year, losing 60.7% versus a loss of 91.3%. CalciMedica is the larger company by market cap ($10.1 million vs $10.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CALC-91.27%CMMB-60.69%
+108%+4%-101%
Oct 7, 20251 yearOct 7, 2026
CALC-94.12%CMMB-79.97%
+40%-30%-101%
Jun 12, 20235 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CALC versus CMMB key metrics
MetricCALCCMMB
Share price$1.48$1.37
Market cap$10.11M$10.04M
1-day change0.00%-2.14%
YTD return-95.51%-16.97%
1-year return-91.27%-60.69%
5-year return—-96.23%
EPS (TTM)$-6.85$-1.04
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$36.00$3.55
52-week low$1.42$1.05
Distance from 52-week high-95.89%-61.41%
Average volume74.07K152.77K
Shares outstanding6.83M7.33M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CMMB has outperformed CALC by 30.6 percentage points over the past year.

CALC vs CMMB FAQ

Which is bigger, CalciMedica or Chemomab Therapeutics?

CalciMedica (CALC) is larger, with a market capitalization of $10.11M compared with $10.04M for Chemomab Therapeutics (CMMB).

Which stock has performed better over the past year, CALC or CMMB?

CMMB returned -60.69% over the past 12 months, compared with -91.27% for CALC (price return, excluding dividends). Past performance does not predict future results.

Are CalciMedica and Chemomab Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons